Use of β-Adrenoceptor Antagonists in Older Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Co-Morbidity: Safety Issues

Author： Andrus Miranda R. Loyed Joyce V.

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.25, Iss.2, 2008-01, pp. : 131-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimising the Use of β-Adrenoceptor Antagonists in Coronary Artery Disease

By Ellison Kristin E.

Drugs, Vol. 65, Iss. 6, 2005-01 ,pp. : 787-797

Adis International

Access to resources Recommend Favorite

Cardiovascular Safety of 2-Adrenoceptor Agonist Use in Patients with Obstructive Airway Disease: A Systematic Review

By Salpeter S.R.

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 405-414

Adis International

Access to resources Recommend Favorite

Inhaled 2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease

By Cazzola Mario

Drugs, Vol. 65, Iss. 12, 2005-01 ,pp. : 1595-1610

Adis International

Access to resources Recommend Favorite

Chronic Obstructive Pulmonary Disease: An Update on Diagnosis and Management Issues in Older Adults

By Nazir Shoab A. Erbland Marcia L.

Drugs & Aging, Vol. 26, Iss. 10, 2009-10 ,pp. : 813-831

Adis International

Access to resources Recommend Favorite

β-Adrenoceptor Antagonists in Elderly Patients with Chronic Heart Failure: Therapeutic Potential of Third-Generation Agents

By Coats Andrew J.S.

Drugs & Aging, Vol. 23, Iss. 2, 2006-01 ,pp. : 93-99

Adis International

Access to resources Recommend Favorite